Descripción

Safety and adverse event data from the 24-week LLLT trial, documenting treatment tolerability and device-related side effects in both active and sham groups.

Figure 23

Chart

Source Paper

Low-level laser therapy for the treatment of androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device-controlled …

Lasers in medical science (2019)

PMID: 30569416

DOI: 10.1007/s10103-018-02699-9

Cite This Figure

![Figure 23: Safety and adverse event data from the 24-week LLLT trial, documenting treatment tolerability and device-related side effects in both active and sham groups.]()

> Source: Poonkiat Suchonwanit et al. "Low-level laser therapy for the treatment of androgenetic alopecia in Thai men a." *Lasers in medical science*, 2019. PMID: [30569416](https://pubmed.ncbi.nlm.nih.gov/30569416/)

<figure>
  <img src="" alt="Safety and adverse event data from the 24-week LLLT trial, documenting treatment tolerability and device-related side effects in both active and sham groups." />
  <figcaption>Figure 23. Safety and adverse event data from the 24-week LLLT trial, documenting treatment tolerability and device-related side effects in both active and sham groups.<br>  Source: Poonkiat Suchonwanit et al. "Low-level laser therapy for the treatment of androgenetic alopecia in Thai men a." <em>Lasers in medical science</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30569416/">30569416</a></figcaption>
</figure>

Evidencia relacionada

Terapia Láser de Baja Intensidad para Alopecia Androgenética

Calificación A · 60 estudios

Terapia Láser de Baja Intensidad para Pérdida Capilar de Patrón Femenino

Calificación A · 14 estudios